SALV.L Regulatory News (SALV)

SALV.L Information

There is currently no data for SALV

REMOVE ADS

Suspension - 3Legs Resoures plc

4 Nov 2015 07:30

RNS Number : 4427E

AIM

04 November 2015

NOTICE

4/11/2015 7:30am

TEMPORARY SUSPENSION OF TRADING ON AIM

3LEGS RESPOURCES PLC

At the request of the Company trading on AIM for the under-mentioned securities has been temporarily suspended from 4/11/2015 7:30am, pursuant to AIM Rule 15.

ORDINARY SHARES OF 0.025P EACH FULLY PAID (B52P5P7) (IM00B52P5P72)

If you have any queries relating to the above, please contact the company's nominated adviser on 020 7382 1100.

This information is provided by RNS

The company news service from the London Stock Exchange

END

EXCLLFVRLILVIIE

Date		Source	Headline
9th Jan 2020	2:30 pm	RNS	Cancellation of trading on AIM
20th Dec 2019	10:30 am	RNS	Cancellation of AIM listing /Potential acquisition
27th Sep 2019	11:07 am	RNS	Half-year Report - Correction
26th Sep 2019	2:06 pm	RNS	Half-year Report
23rd Sep 2019	3:02 pm	RNS	AIM Rule 17 Notification
9th Jul 2019	7:30 am	RNS	Suspension - SalvaRx Group Plc
9th Jul 2019	7:30 am	RNS	Suspension of Trading
28th Jun 2019	11:26 am	RNS	Final Results
31st Jan 2019	7:00 am	RNS	Change of Nominated Adviser and Broker
17th Jan 2019	2:05 pm	RNS	Second Price Monitoring Extn
17th Jan 2019	2:00 pm	RNS	Price Monitoring Extension
8th Jan 2019	4:15 pm	RNS	Result of AGM and Completion of Disposal
4th Jan 2019	5:30 pm	RNS	Salvarx Group
14th Dec 2018	7:50 am	RNS	Nominated Adviser Status
10th Dec 2018	7:00 am	RNS	Issue of US$1 million of Loan Notes by iOx
27th Nov 2018	7:00 am	RNS	Posting of Circular and Notice of AGM
21st Nov 2018	1:00 pm	RNS	Transaction Update
6th Nov 2018	7:00 am	RNS	Director/PDMR Dealing
22nd Oct 2018	9:47 am	RNS	Intensity Therapeutics Update
9th Oct 2018	7:00 am	RNS	Exercise of Warrants
27th Sep 2018	7:00 am	RNS	Half-year Report
28th Aug 2018	5:40 pm	RNS	Update re proposed disposal and demerger
14th Aug 2018	7:00 am	RNS	Proposed disposal of interest in SalvaRx Limited
1st Aug 2018	4:40 pm	RNS	Second Price Monitoring Extn
1st Aug 2018	4:35 pm	RNS	Price Monitoring Extension
23rd Jul 2018	1:17 pm	RNS	Delay in iOx development programme
28th Jun 2018	7:00 am	RNS	Final Results
26th Jun 2018	7:00 am	RNS	Related Party Loan of US$1 million
8th Mar 2018	12:00 pm	RNS	Drug Pipeline Progress and iOx Loan Note Issue
30th Oct 2017	4:40 pm	RNS	Second Price Monitoring Extn
30th Oct 2017	4:35 pm	RNS	Price Monitoring Extension
23rd Oct 2017	7:00 am	RNS	Subscriptions for SalvaRx Ltd Loan Facility
27th Sep 2017	9:00 am	RNS	Half-year Report
25th Sep 2017	8:00 am	RNS	Formation of Saugatuck Therapeutics
1st Aug 2017	3:30 pm	RNS	Holding(s) in Company
1st Aug 2017	3:30 pm	RNS	Holding(s) in Company
31st Jul 2017	1:45 pm	RNS	Result of AGM
5th Jul 2017	3:03 pm	RNS	Notice of AGM
30th Jun 2017	8:34 am	RNS	Final Results
30th May 2017	12:45 pm	RNS	Intensity Therapeutics Treats First Patient
20th Mar 2017	7:00 am	RNS	Investment in Rift Biotherapeutics
2nd Mar 2017	7:00 am	RNS	Restructuring, Loan Conversion and Loan Facility
28th Feb 2017	7:00 am	RNS	Investment in Nekonal
2nd Feb 2017	4:37 pm	RNS	Intensity Therapeutics
3rd Oct 2016	4:40 pm	RNS	Second Price Monitoring Extn
3rd Oct 2016	4:35 pm	RNS	Price Monitoring Extension
14th Sep 2016	7:00 am	RNS	Corporate Video
13th Sep 2016	7:00 am	RNS	Half-year Report
22nd Aug 2016	7:00 am	RNS	Drug Pipeline Progress including Patent Grants
4th Aug 2016	2:05 pm	RNS	Result of AGM

Latest Share Chat

SALV.L Regulatory News (SALV)

Suspension - 3Legs Resoures plc

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending